What "personal cell banking" actually is
Autologous cell banking is the process of collecting your own cells — typically bone marrow aspirate, adipose tissue, or dental pulp — expanding them under GMP conditions, and cryopreserving them for possible future use. The pitch is preventive: bank now, when your cells are younger and healthier, so you have a personal supply for later treatment.
Some patients considering a treatment trip to Colombia (or elsewhere) ask whether they can bank additional cells during the same visit. It is a reasonable question with several honest answers.
What can be banked
- Bone marrow-derived MSCs — extracted from an aspirate, expanded, cryopreserved. The most established banking pathway.
- Adipose-derived MSCs — extracted from a small liposuction sample, similarly expanded and stored. Often more comfortable for the patient than marrow aspiration.
- Dental pulp stem cells — extracted from wisdom teeth or baby teeth if you are having them removed anyway.
What you receive is a series of cryopreserved aliquots — usually multiple vials at defined cell counts, stored in liquid nitrogen at the banking facility, with annual storage fees.
Honest questions about the utility
Will the banked cells actually be useful?
This depends on regulatory evolution. Under current INVIMA and FDA frameworks, using banked, culture-expanded autologous cells requires an authorized cell therapy center and an approved (or investigational) indication. Your banked cells are not something you can just "cash in" at any clinic in ten years. They are useful only within the regulatory pathways available at the time you want to use them.
How long do banked cells stay viable?
Properly cryopreserved MSCs retain viability for many years in liquid nitrogen. Precise upper limits are still being characterized, but data supports at least a decade of stable storage with proper conditions. The failure mode is usually facility-level (a freezer failure, a facility closure) rather than time-driven degradation.
What are the ongoing costs?
Initial collection, processing, and expansion runs several thousand dollars typically. Annual storage fees are additional — figure a few hundred dollars per year, sometimes bundled into multi-year prepayment plans. Over 20 years of storage, cumulative cost can rival or exceed the initial collection price.
When banking during a treatment trip makes sense
- You are already in Colombia for treatment, and marginal cost of collecting extra cells is lower than a separate trip later.
- You have a family history of conditions where regenerative medicine may develop future applications (specific autoimmune or degenerative diseases).
- You are relatively young (30s–50s) and want a "younger cell" supply available if regulations expand.
When it does not
- You are being pushed into banking as an add-on with vague future-use promises.
- The banking facility is unaccredited or does not disclose its cryopreservation protocols.
- The cost is being framed as insurance without honest discussion of regulatory uncertainty about future use.
The most honest framing: you are paying now for optionality later. Whether that optionality translates into usable therapy depends on how regulations evolve, what indications get approved, and whether banking facilities remain operational and accessible to you. It is not a guaranteed return.
Thinking about banking during your treatment trip?
We help patients evaluate whether banking makes sense for their situation. Message us on WhatsApp.
Ask a question on WhatsApp